2009 Fiscal Year Final Research Report
Development of the new treatment strategy for cancer using the transgenic mice that induced the epithelial tumors
| Project/Area Number |
19591927
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Obstetrics and gynecology
|
|---|
| Research Institution | Kawasaki Medical School (2008-2009)
University of Toyama (2007) |
|---|
Principal Investigator |
NAKAMURA Takafumi Kawasaki Medical School, 医学部, 教授 (20303969)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
SAITO Shigeru 富山大学, 大学院・医学薬学研究部, (医学)教授 (30175351)
YAMAMOTO Hiroshi 富山大学, 生命科学先端研究センター, 准教授 (00108797)
|
|---|
| Project Period (FY) |
2007 – 2009
|
| Keywords | SV40T抗原 / トランスジェニックマウス / 水晶体腫瘍 / 自然免疫マクロファージ / NK細胞 / 漢方薬 |
|---|
| Research Abstract |
Herbal medicine (Juzentaihoto, Hochuekkito) extended duration of life of cancer bearing laboratory mouse significantly. These herbal medicine are able to activate natural immunity, and there would be a possibility that the immunology of cancer bearing laboratory mouse might be activated.
|
